Literature DB >> 24637292

Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets.

Xingshen Sun1, Alicia K Olivier2, Yaling Yi1, Christopher E Pope3, Hillary S Hayden4, Bo Liang1, Hongshu Sui1, Weihong Zhou1, Kyle R Hager4, Yulong Zhang1, Xiaoming Liu1, Ziying Yan1, John T Fisher1, Nicholas W Keiser1, Yi Song1, Scott R Tyler1, J Adam Goeken2, Joann M Kinyon5, Matthew C Radey4, Danielle Fligg5, Xiaoyan Wang1, Weiliang Xie1, Thomas J Lynch1, Paul M Kaminsky1, Mitchell J Brittnacher4, Samuel I Miller6, Kalpaj Parekh7, David K Meyerholz2, Lucas R Hoffman3, Timothy Frana5, Zoe A Stewart8, John F Engelhardt9.   

Abstract

Cystic fibrosis (CF) is a multiorgan disease caused by loss of a functional cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel in many epithelia of the body. Here we report the pathology observed in the gastrointestinal organs of juvenile to adult CFTR-knockout ferrets. CF gastrointestinal manifestations included gastric ulceration, intestinal bacterial overgrowth with villous atrophy, and rectal prolapse. Metagenomic phylogenetic analysis of fecal microbiota by deep sequencing revealed considerable genotype-independent microbial diversity between animals, with the majority of taxa overlapping between CF and non-CF pairs. CF hepatic manifestations were variable, but included steatosis, necrosis, biliary hyperplasia, and biliary fibrosis. Gallbladder cystic mucosal hyperplasia was commonly found in 67% of CF animals. The majority of CF animals (85%) had pancreatic abnormalities, including extensive fibrosis, loss of exocrine pancreas, and islet disorganization. Interestingly, 2 of 13 CF animals retained predominantly normal pancreatic histology (84% to 94%) at time of death. Fecal elastase-1 levels from these CF animals were similar to non-CF controls, whereas all other CF animals evaluated were pancreatic insufficient (<2 μg elastase-1 per gram of feces). These findings suggest that genetic factors likely influence the extent of exocrine pancreas disease in CF ferrets and have implications for the etiology of pancreatic sufficiency in CF patients. In summary, these studies demonstrate that the CF ferret model develops gastrointestinal pathology similar to CF patients.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24637292      PMCID: PMC4005986          DOI: 10.1016/j.ajpath.2014.01.035

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Abdominal manifestations of cystic fibrosis in children.

Authors:  Gulraiz Chaudry; Oscar M Navarro; Daniel S Levine; Kamaldine Oudjhane
Journal:  Pediatr Radiol       Date:  2006-01-04

2.  Risk factors for small bowel bacterial overgrowth in cystic fibrosis.

Authors:  Jacqueline L Fridge; Carol Conrad; Lauren Gerson; Ricardo O Castillo; Kenneth Cox
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-02       Impact factor: 2.839

Review 3.  Nutritional management of cystic fibrosis patients.

Authors:  Daina Kalnins; Peter R Durie; Paul Pencharz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-05       Impact factor: 4.294

Review 4.  Cystic fibrosis mouse models.

Authors:  Claudine Guilbault; Zienab Saeed; Gregory P Downey; Danuta Radzioch
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-03       Impact factor: 6.914

5.  Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.

Authors:  David K Meyerholz; David A Stoltz; Alejandro A Pezzulo; Michael J Welsh
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

Review 6.  Pancreatic exocrine function in patients with cystic fibrosis.

Authors:  Susan S Baker; Drucy Borowitz; Robert D Baker
Journal:  Curr Gastroenterol Rep       Date:  2005-06

7.  Calpain inhibition attenuates iNOS production and midzonal hepatic necrosis in a repeat dose model of endotoxemia in rats.

Authors:  Robert Rose; Atrayee Banerjee; Shashi K Ramaiah
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

Review 8.  Hepatobiliary disease in patients with cystic fibrosis.

Authors:  Katie Moyer; William Balistreri
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

9.  Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets.

Authors:  Xingshen Sun; Ziying Yan; Yaling Yi; Ziyi Li; Diana Lei; Christopher S Rogers; Juan Chen; Yulong Zhang; Michael J Welsh; Gregory H Leno; John F Engelhardt
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer.

Authors:  Christopher S Rogers; Yanhong Hao; Tatiana Rokhlina; Melissa Samuel; David A Stoltz; Yuhong Li; Elena Petroff; Daniel W Vermeer; Amanda C Kabel; Ziying Yan; Lee Spate; David Wax; Clifton N Murphy; August Rieke; Kristin Whitworth; Michael L Linville; Scott W Korte; John F Engelhardt; Michael J Welsh; Randall S Prather
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more
  40 in total

1.  Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.

Authors:  Mark Bazett; Lisa Honeyman; Anguel N Stefanov; Christopher E Pope; Lucas R Hoffman; Christina K Haston
Journal:  Mamm Genome       Date:  2015-02-27       Impact factor: 2.957

Review 2.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

3.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

4.  Chronic Pancreatitis in the 21st Century - Research Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Aliye Uc; Dana K Andersen; Melena D Bellin; Jason I Bruce; Asbjørn M Drewes; John F Engelhardt; Christopher E Forsmark; Markus M Lerch; Mark E Lowe; Brent A Neuschwander-Tetri; Stephen J OʼKeefe; Tonya M Palermo; Pankaj Pasricha; Ashok K Saluja; Vikesh K Singh; Eva M Szigethy; David C Whitcomb; Dhiraj Yadav; Darwin L Conwell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

5.  Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets.

Authors:  Pavana G Rotti; Weiliang Xie; Ananta Poudel; Yaling Yi; Xingshen Sun; Scott R Tyler; Aliye Uc; Andrew W Norris; Manami Hara; John F Engelhardt; Katherine N Gibson-Corley
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

Review 6.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

7.  In Situ Analysis Reveals That CFTR Is Expressed in Only a Small Minority of β-Cells in Normal Adult Human Pancreas.

Authors:  Michael G White; Rashmi R Maheshwari; Scott J Anderson; Rolando Berlinguer-Palmini; Claire Jones; Sarah J Richardson; Pavana G Rotti; Sarah L Armour; Yuchun Ding; Natalio Krasnogor; John F Engelhardt; Mike A Gray; Noel G Morgan; James A M Shaw
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 8.  Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.

Authors:  Meike Hohwieler; Lukas Perkhofer; Stefan Liebau; Thomas Seufferlein; Martin Müller; Anett Illing; Alexander Kleger
Journal:  United European Gastroenterol J       Date:  2016-09-21       Impact factor: 4.623

Review 9.  The CF gastrointestinal microbiome: Structure and clinical impact.

Authors:  Geraint B Rogers; Michael R Narkewicz; Lucas R Hoffman
Journal:  Pediatr Pulmonol       Date:  2016-10

10.  Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.

Authors:  Ziying Yan; Xingshen Sun; Zehua Feng; Guiying Li; John T Fisher; Zoe A Stewart; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2015-04-20       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.